Medical research:

Research news

a field that is dismally neglected by corporate sponsors

Never before has business been so frequently called upon by charitable organizations to donate funds; indeed, we are witnessing a period of growing government withdrawal of financial support to fields of public interest.

The year 2010 was marked by a paradox—the number of corporations granting subsidies considerably increased (+17%), but at the same time the overall budget was cut by 20%.

Indeed, two billion euros (compared to 2.5 in 2008) were consecrated to financial sponsorship by around 35,000 business firms.

Social, educational and health fields were in the forefront for receiving donations, with 36% of the budget (around 720 million euros).  Next came sports (19%), culture and heritage (19%), international solidarity (11%) and the environment (11%).

Research (all fields combined, including medical research)  came in last  (4%); and in addition, the funds collected  were considerably less  in 2010--around 80 million euros compared to 225 million euros  in 2008!

And yet :

Citizens in our day and ago probably expect  more of the corporate world and of their employers than ever before.   Above and beyond questions of financial transparency and   honest governing, the responsibility of industry  in present-day  society is being demanded, examined and evaluated.  Sponsorship, which is above all a free choice, represents one of the major ways in which industry can rise to the occasion.

It is rare at present that a company  only grant subsidies in one single area:   the average is  1.9 compared to 1.3 in 2008.  Such diversification might be an opportunity to boost the funding of medical research. 

 

References

Le mécénat d’entreprise en France – Résultats de l’enquête Admical-CSA – 2010

 

Subscribe to our newsletter!
Newsletter en français
Newsletter in english

Le cumul des maladies : bonne ou mauvaise chose ?

 Le foie et l’intestin sont 2 organes intimement liés et semblant « communiquer »...

Read more…


Can anti-TNF treatment be interrupted ?

A recent prospective study called Stori, carried out by GETAID (a therapeutic study group devoted to inflammatorydiseases of the digestive tract)

Read more…


Your employer appreciates your treatment !

The effect of adalimumab upon work productivity

Read more…